Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,010 | 186,309 | 30,521 | 20,328 | 20,118 |
| Marketable Securities | 224,646 | 95,383 | 113,634 | 144,486 | 168,792 |
| Receivables | 186 | 350 | 489 | 505 | 831 |
| TOTAL | $258,985 | $285,790 | $148,981 | $169,193 | $193,189 |
| Non-Current Assets | |||||
| PPE Net | 45,526 | 46,417 | 47,344 | 48,370 | 51,815 |
| Intangibles | 98,100 | 98,100 | 98,100 | 98,100 | 98,100 |
| Other Non-Current Assets | 181 | 205 | 281 | 253 | 304 |
| TOTAL | $143,807 | $144,722 | $145,725 | $146,723 | $150,219 |
| Total Assets | $402,792 | $430,512 | $294,706 | $315,916 | $343,408 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,478 | 1,443 | 1,413 | 1,380 | 1,155 |
| Accounts payable and accrued liabilities | 5,324 | 6,042 | 5,526 | 3,671 | 5,452 |
| Accrued Expenses | 13,710 | 13,786 | 7,703 | 8,037 | 7,688 |
| TOTAL | $20,933 | $21,390 | $14,806 | $13,226 | $14,480 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,063 | 23,451 | 23,826 | 24,188 | 27,044 |
| Deferred Revenues | 421 | 119 | 164 | 138 | 185 |
| Other Non-Current Liabilities | 57,170 | 55,146 | 53,636 | 51,357 | 49,610 |
| TOTAL | $112,888 | $111,554 | $110,419 | $108,502 | $109,611 |
| Total Liabilities | $133,821 | $132,944 | $125,225 | $121,728 | $124,091 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,686 | 68,672 | 48,254 | 48,254 | 48,252 |
| Common Shares | 481 | 480 | 338 | 338 | 338 |
| Retained earnings | -819,489 | -789,621 | -755,776 | -729,673 | -703,035 |
| Other shareholders' equity | 313 | -324 | -311 | -274 | -305 |
| TOTAL | $268,971 | $297,568 | $169,481 | $194,188 | $219,317 |
| Total Liabilities And Equity | $402,792 | $430,512 | $294,706 | $315,916 | $343,408 |